Dr. Campbell Rogers, Executive Vice President and Chief Medical Officer at HeartFlow discusses some of the latest developments in cardiovascular care, including HeartFlow’s technology, which leverages artificial intelligence to create a personalized 3D model of a patient’s heart to help physicians diagnose heart disease, the leading cause of death in the world.
Dr. Campbell Rogers is Executive Vice President and Chief Medical Officer at HeartFlow. Prior to joining HeartFlow, he served as the Chief Scientific Officer and Global Head of Research and Development at Cordis Corporation, Johnson & Johnson, where he was responsible for leading investments and research in cardiovascular devices. Prior to Cordis, he was Associate Professor of Medicine at Harvard Medical School and the Harvard-M.I.T. Division of Health Sciences and Technology, and Director of the Cardiac Catheterization and Experimental Cardiovascular Interventional Laboratories at Brigham and Women’s Hospital. He served as Principal Investigator for numerous interventional cardiology device, diagnostic and pharmacology trials, is the author of numerous journal articles, chapters, and books in the area of coronary artery and other cardiovascular diseases and was the recipient of research grant awards from the NIH and AHA. He received his A.B. from Harvard College and his M.D. from Harvard Medical School.